Gastroenterology Conference - All PresentationsOriginal Date: August 13-14, 2022This discounted package includes all of the individual presentations from the conference, which are listed below.12.0 CEUs (including 9.75 general and 2.25 pharmacy) approved by OBNM
Gut Microbiome and Autoimmunity: Focus on Bacteria Connected to Varied Autoimmune ConditionsPresenter: Jaquel Patterson, NDOriginal Date: August 13, 2022Individuals with autoimmune conditions often have a wide variety of gastrointestinal manifestations. The gut microbiota helps the body to discriminate self from non-self which can positively or negatively impact the disease condition. Studies have also linked proteins that are produced by common gut bacteria which can trigger up the onset of autoimmune diseases like multiple sclerosis, rheumatoid arthritis, and ulcerative colitis. The presentation this intricate balance with the gut microbiota and how to support for future prevention and for maintenance of an autoimmune condition.1.5 CEUs (including 1.25 general and 0.25 pharmacy) approvedby OBNM
IBS and Microbial MetabolitesPresenter: Heather Zwickey, PhDOriginal Date: August 13, 2022Irritable Bowel Syndrome (IBS) is a diagnosis that highlights the cross-talk between brain and gut. The microbial communities in the gut wield remarkable influence over human health and disease, including IBS. However, the complexity of the gut microbiota between individuals makes it challenging to identify putative causative agents of a particular disease phenotype. Microbial metabolites may provide IBS insights that the presence or absence of particular microbes cannot. In this seminar, we will evaluate the role of microbial metabolites, including bile acids, short-chain fatty acids, tryptophan derivatives and indole derivatives for their roles in IBS. As research around the microbiome and microbial metabolites grows, treating the cause of IBS may be more in reach.1.5 CEUs (including 1.5 general) approvedby OBNM
Autoimmune Hepatobiliary Conditions: Learning from Three Liver Autoimmune Conditions - Biliary Cirrhosis and Primary Sclerosing CholangitisPresenter: Eric Yarnell, ND, AHGOriginal Date: August 13, 2022The naturopathic diagnosis and co-management of patients with PBC, PSC and autoimmune hepatitis will be reviewed. They will also be used a cases to study links between the liver and gastroenterology.1.5 CEUs (including 1.25 general and 0.25 pharmacy) pending approved by OBNM
Review, Update and Comparison of Lab Tests for the Functional GI CasePresenter: Ilana Gurevich, ND, LAcOriginal Date: August 13, 2022Discuss difference testing that is on a functional GI panel and present clinical data on the efficacy and use of testing on this panel.1.5 CEUs (including 1.5 general) approvedby OBNM
In CASE You Were Wondering! Exploring the Interplay between Gastroenterology, Pharmacogenomics and Nutrigenomics Through Three Rare CasesPresenter: Leah Hollon, ND & Carrie Hoefer, PhDOriginal Date: August 14, 2022Drawing from their advanced microbiology published paper on The Role of the Human Gutome on Chronic Disease: The speakers will help us understand the applications of pharmacogenomics/nutrigenomics within ND cases, through the study of cases interconnecting both through a focus on gastroenterology. This presentation will take the audience through 2-3 rare cases involved in gastroenterology exploring patient outcomes, along with the genetics related to nutrition and drug therapy that may have been either related to the patient outcomes, or what could have been done further based on the patient outcomes.1.5 CEUs (including 0.5 general and 1.0 pharm) approvedby OBNM
Neurodegeneration and gut health: is there a connection? Microbiome, Alzheimer's and Parkinson'sPresenter: Medeya Tsnobiladze, ND, MSOriginal Date: August 14, 2022Alzheimer’s (AD) and Parkinson’s (PD) diseases are the two most prevalent neurodegenerative conditions in the USA. They together affect over 7 million people. While very different clinically, these two conditions have similar pathophysiologic features. While initially affecting different groups of neurons, both conditions lead to neuronal loss. Proteinaceous aggregations found in Alzheimer’s and Parkinson’s are different, but both conditions are kinds of amyloidosis. There is a growing body of data showing that both these neurodegenerative conditions can be connected to gut health and microbiome disruption that may precede the onset of AD and PD by years, if not decades.In this presentation we will explore mechanisms by which processes in the gut may start neurodegeneration in the brain, characteristic microbiome changes, and possible interventions that may prevent or slow down progression of the disease.1.5 CEUs (including 1.25 general and 0.25 pharm) approved by OBNM
Investigating Diverticular DiseasePresenter: Christine Bowen, NDOriginal Date: August 14, 2022Diverticular diseases are common and poorly understood. If they are not managed swiftly and correctly, they could be life threatening conditions. We will review the subtypes and discuss existing literature, conventional and holistic management. We will also discuss possible preventive measures and will review a few case studies.1.5 CEUs (including 1.25 general and 0.25 pharm) approved by OBNM
Tryptophan, Metabolism and the GutPresenter: Adam Rinde, NDOriginal Date: August 14, 2022This talk will explore tryptophan and its connection to aryl-hydrocarbon receptor/Indole pathways, serotonin pathways, and kynurenine pathways. The goal will be understanding how these pathways may inform us on how to better to treat gut disorders like IBS as well following metabolic connections.1.5 CEUs (including 1.25 general and 0.25 pharm) approved by OBNM
